Name: Molecular Biology Enzymes And Kits and Reagents Diagnosis Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: CD4354
Price: 4350 USD
Availability: InStock

Molecular Biology Enzymes and Kits and Reagents Diagnosis Market 2030

Molecular Biology Enzymes And Kits and Reagents Diagnosis Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market is segmented By Product Type( Kits &amp; Reagents, Enzymes, Polymerases, Restriction Endonucleases, Reverse Transcriptases, Other), By Application (PCR, Sequencing, Cloning, Epigenetics, Other), By End-User(Academic &amp; Research Institutes, Pharmaceutical &amp; Biotechnology companies, Hospitals &amp; Diagnostic Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

&nbsp;

<blockquote>
The Molecular Biology Enzymes and Kits &amp; Reagents Market&nbsp;size was valued at US$ XX million in 2022&nbsp;and is estimated to reach US$ XX million by 2029, growing at a high CAGR&nbsp;during the forecast period (2023-2030).&nbsp;
</blockquote>

The study of the molecular basis of biological activity is known as molecular biology. Molecular biology provides new insights into the nature of genes and proteins, as well as their interactions. In contrast, time-honoured biochemical and physiological approaches can demonstrate how the disease affects function at the cell, tissue, organ, and individual levels.

Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Scope

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			High
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Product Type,&nbsp;By Ingredient,&nbsp;By Form,&nbsp;By Application,&nbsp;and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

<h3>Market Dynamics</h3>

The factors driving the molecular biology enzymes and kits &amp; reagents diagnosis market are growing research and development.

The growing research and development is expected to drive the global molecular biology enzymes and kits &amp; reagents diagnosis market in the forecast period&nbsp;

Gene mutations are important in the etiology and progression of diseases and disorders such as immune system disorders, metabolic diseases, cancer, and in-born genetic disorders. As a result, understanding the etiology of specific diseases and developing treatment plans can be significantly aided by detailed knowledge of the human genome. The growing number of genome projects around the world, combined with lower genetic analysis costs, aids in advancing research in various fields, including disease treatment, personalized medicine, and microbial genetics. The availability of vast and remarkable data resources has encouraged and enhanced numerous advances in science and technology within and beyond genetics and genomics. The approach used in these diseases has been successfully applied to a wide range of other complex diseases. The bacteriophage T4 DNA ligase is the most commonly used in molecular biology. T4 DNA ligase is a 68 kDa monomer that requires the cofactors Mg2+ and ATP. T4 DNA ligase can repair single-stranded nicks in duplex DNA, RNA, or DNA/RNA hybrids and connect blunt and cohesive ends. Since molecular cloning has become a standard laboratory technique, manufacturers provide a plethora of enzymes for the generation and manipulation of nucleic acids.

The limitations are expected to hamper the molecular biology enzymes and kits &amp; reagents diagnosis market

The reimbursement policies for genetic tests are rigid. Unless prescribed by a physician, most health insurance plans in the United States do not cover the cost of genetic testing. The provider&#39;s policy solely determines coverage and reimbursement. For example, Medicare covers genetic testing for people with cancer who qualify for Medicare genetic testing for an inherited mutation. Such concerns are stifling market growth around the world.

<h3>COVID-19 Impact Analysis&nbsp;</h3>

COVID-19 is an acute respiratory infectious disease caused by the SARS coronavirus 2 (SARSCoV2). COVID-19, which was largely unknown before the outbreak began in Wuhan (China) in December 2019, has quickly progressed from a regional crisis to a global pandemic. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. Researchers have been working to develop diagnostic methods and treatments to combat this pandemic. Because of their accuracy and reliability in detecting genetic materials from the virus in the host&#39;s body, PCR tests have been considered the &quot;gold standard&quot; for diagnosing COVID-19. Hence, the COVID-19 is assumed to impact the market growth.

<h3>Segment Analysis</h3>

Polymerase Chain Reaction Segment is expected to dominate the global molecular biology enzymes and kits &amp; reagents diagnosis market

The rising prevalence of genetic, infectious, and chronic diseases is primarily responsible for the segment&#39;s growth. PCR-based tests are increasingly being used to guide patient management, especially in infectious disease, cancer, and congenital abnormalities. According to the World Health Organization, cancer is the second leading cause of death worldwide, accounting for 9.6 million deaths in 2018. PCR techniques are commonly used for tumor profiling and bacterial infection detection. PCR is also used in DNA sequencing, cloning, library generation, mutagenesis, and expression profiling. PCR duplicates the nucleic acid strands to increase the size of the DNA. Thermal cyclers and reagents such as enzymes, nucleotides, and buffers denature and anneal DNA strands during amplification.

&nbsp;However, technological advancements and high demand for automated workstations have increased the adoption of real-time PCR and digital PCR techniques to simplify workflow in busy, high-throughput laboratories. PCR is now a common and often necessary technique in medical and biological research labs for many applications. The PCR technique consists of three significant steps: denaturation, annealing, and extension. A growing number of diseases can be investigated and diagnosed using PCR. Human genes, as well as genes from bacteria and viruses, can be detected using qualitative PCR. It is also used in forensics laboratories and is particularly useful because it requires only a small amount of original DNA. PCR can identify genes that have been linked to cancer development. The emergence of PCR as a technique has aided molecular cloning.

<h3>Geographical Analysis</h3>

North America region accounted for the largest market share in the global molecular biology enzymes and kits &amp; reagents diagnosis market

The increasing research funds in clinical research, the growing number of pharmaceutical and biotechnology companies, the favourable reimbursement scenario for molecular diagnostics, and the growing investments in research projects in Canada are projected to drive the market in this region. Many clinical research organizations in this region are expected to contribute to the market growth. For instance, As of 2021, there are 4,087 Contract Research Organizations businesses in the United States, a 3.4 per cent increase from 2020.

<h3>Competitive Landscape</h3>

The global molecular biology enzymes and kits &amp; reagents diagnosis market is highly competitive with increasing research &amp; developments, company mergers, and acquisitions. Some of the major key players in the market are Thermo Fisher, Merck, Illumina,&nbsp; New England Biolabs, Promega, Agilent, Roche, Takara Bio, Bio Basic, Jena Bioscience

Thermo Fisher Scientific

Overview: Thermo Fisher Scientific is based in the United States that sells scientific instruments, reagents and consumables, and software services. Waltham, Massachusetts, is the company&#39;s headquarters. The company was founded in 1956.

Product Portfolio: The company manufactures PCR enzymes and reagents for applications in molecular biology. Using well-known and trusted PCR enzymes such as Applied Biosystems AmpliTaq and AmpliTaq Gold, Invitrogen Platinum II Taq, and Platinum SuperFi II DNA polymerases.

Key Development: On April 15th, 2021, Thermo Fisher Scientific Inc. acquired PPD for $47.50 per share, for a total cash purchase price of $17.4 billion, plus the assumption of approximately $3.5 billion in net debt.

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Frequently Asked Questions</h3>

What is the Projected CAGR value of the Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market?

Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market is expected to grow at a high CAGR during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America&nbsp;region Controls&nbsp;the&nbsp;Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market&nbsp;during 2022-2029.

Which is the fastest growing region in the Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market?

Among all regions,&nbsp;Asia Pacific&nbsp;is the fastest growing market share during the forecast period.

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/download-sample/poc-molecular-diagnostics-market">POC Molecular Diagnostics Market</a>

<a href="https://www.datamintelligence.com/download-sample/molecular-diagnostics-market">Molecular Diagnostics Market</a>

<a href="https://www.datamintelligence.com/download-sample/molecular-cytogenetics-market">Molecular Cytogenetics Market</a>

&nbsp;

&nbsp;

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet By Product Type</li>
		<li>Market Snippet By Application</li>
		<li>Market Snippet By End-User</li>
		<li>Market Snippet By Region&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>The growing research and development</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>The limitations are expected to hamper the market</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Product Type&nbsp;</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
		<li>Market Attractiveness Index, By Product Type&nbsp;
		<ol>
			<li>Kits &amp; Reagents*
			<ol>
				<li>Introduction</li>
				<li>Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2020-2029</li>
			</ol>
			</li>
			<li>Enzymes</li>
			<li>Polymerases</li>
			<li>Restriction Endonucleases</li>
			<li>Reverse Transcriptases</li>
			<li>Other</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>By Application&nbsp;</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
		<li>Market Attractiveness Index, By Application&nbsp;
		<ol>
			<li>PCR*
			<ol>
				<li>Introduction</li>
				<li>Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2020-2029</li>
			</ol>
			</li>
			<li>Sequencing&nbsp;</li>
			<li>Cloning</li>
			<li>Epigenetics</li>
			<li>Other</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User&nbsp;</li>
			<li>Market Attractiveness Index, By End-User&nbsp;</li>
		</ol>
		</li>
		<li>Academic &amp; Research Institutes*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2020-2029</li>
		</ol>
		</li>
		<li>&nbsp;Pharmaceutical &amp; Biotechnology companies</li>
		<li>Hospitals &amp; Diagnostic Centers</li>
		<li>&nbsp;Other</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2020-2029, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>Key Developments and Strategies&nbsp;</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>Thermo Fisher Scientific*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Merck</li>
		<li>ILLUMINA</li>
		<li>New England Biolabs</li>
		<li>Promega</li>
		<li>Agilent</li>
		<li>Roche</li>
		<li>Takara Bio</li>
		<li>Bio Basic</li>
		<li>Jena Bioscience(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3>DataM Intelligence&nbsp;&nbsp;</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 01 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market, By Product Type, 2021, 2025 &amp; 2029 ($ Million)

Table 02 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market, By Application, 2021, 2025 &amp; 2029 ($ Million)

Table 03 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2021, 2025 &amp; 2029 ($ Million)

Table 04 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 05 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Product Type, 2021, 2025 &amp; 2029 ($ Million)

Table 06 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Product Type, 2021, 2025 &amp; 2029 ($ Million)

Table 07 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Application, 2021, 2025 &amp; 2029 ($ Million)

Table 08 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 09 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2021, 2025 &amp; 2029 ($ Million)

Table 10 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2019-2029 ($ Million)

Table 11 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 12 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Region, 2019-2029 ($ Million)

Table 13 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 14 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 15 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2019-2029 ($ Million)

Table 16 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 17 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 18 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 19 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2019-2029 ($ Million)

Table 20 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 21 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 22 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 23 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2019-2029 ($ Million)

Table 24 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 25 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 26 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 27 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2019-2029 ($ Million)

Table 28 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 29 Middle East &amp; Africa Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 30 Middle East &amp; Africa Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 31 Middle East &amp; Africa Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, By End-User, 2019-2029 ($ Million)

Table 32 Thermo Fisher Scientific: Overview

Table 33 Thermo Fisher Scientific: Product Portfolio

Table 34 Thermo Fisher Scientific: Key Developments

Table 35 Merck: Overview

Table 36 Merck: Product Portfolio

Table 37 Merck: Key Developments

Table 38 Illumina: Overview

Table 39 Illumina: Product Portfolio

Table 40 Illumina: Key Developments

Table 41 New England Biolabs: Overview

Table 42 New England Biolabs: Product Portfolio

Table 43 New England Biolabs: Key Developments

Table 44 Promega: Overview

Table 45 Promega: Product Portfolio

Table 46 Promega: Key Developments

Table 47 Agilent: Overview

Table 48 Agilent: Product Portfolio

Table 49 Agilent: Key Developments

Table 50 Roche: Overview

Table 51 Roche: Product Portfolio

Table 52 Roche: Key Developments

Table 53 Takara Bio: Overview

Table 54 Takara Bio: Product Portfolio

Table 55 Takara Bio: Key Developments

Table 56 Bio Basic: Overview

Table 57 Bio Basic: Product Portfolio

Table 58 Bio Basic: Key Developments

Table 59 Jena Bioscience: Overview

Table 60 Jena Bioscience: Product Portfolio

Table 61 Jena Bioscience: Key Developments

List of Figures

Figure 01 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 02 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 03 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By End-User, 2021 &amp; 2029 (%)

Figure 04 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Region, 2021 &amp; 2029 (%)

Figure 05 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 06 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Y-o-Y Growth, By Product Type, 2021-2029 (%)

Figure 07 Kits &amp; Reagents: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 08 Enzymes: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 09 Polymerases: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 10 Restriction Endonucleases: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 11 Reverse Transcriptases: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 12 Other: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 13 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Y-o-Y Growth, By Application, 2021-2029 (%)

Figure 14 PCR: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 15 Sequencing: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 16 Cloning: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 17 Epigenetics: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 18 Other: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 19 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Y-o-Y Growth, By End-User, 2021-2029 (%)

Figure 20 Academic &amp; Research Institutes: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 21 Pharmaceutical &amp; Biotechnology companies: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 22 Hospitals &amp; Diagnostic Centers: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 23 Other: Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 24 Global Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 25 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 26 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 27 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 28 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By End-User, 2021 &amp; 2029 (%)

Figure 29 North America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 30 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, 2019-2029 ($ Million)

Figure 31 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 32 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 33 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By End-User, 2021 &amp; 2029 (%)

Figure 34 South America Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 35 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 36 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 37 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 38 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By End-User, 2021 &amp; 2029 (%)

Figure 39 Europe Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 40 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 41 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 42 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 43 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By End-User, 2021 &amp; 2029 (%)

Figure 44 Asia-Pacific Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 45 Middle East &amp; Africa Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Value, 2019-2029 ($ Million)

Figure 46 Middle East &amp; Africa Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 47 Middle East &amp; Africa Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 48 Middle East &amp; Africa Molecular Biology Enzymes And Kits &amp; Reagents Diagnosis Market Share, By End-User, 2021 &amp; 2029 (%)

Figure 49 Thermo Fisher Scientific: Financials

Figure 50 Merck: Financials

Figure 51 ILLUMINA: Financials

Figure 52 New England Biolabs: Financials

Figure 53 Promega: Financials

Figure 54 Agilent: Financials

Figure 55 Roche: Financials

Figure 56 Takara Bio: Financials

Figure 57 Bio Basic: Financials

Figure 58 Jena Bioscience: Financials